Shuai et al. showed that SALL4 expression in bone marrow of MDS and AML patients was significantly higher than control group and correlated with expression of MYC and cyclin D1 (CCND1) which are known downstream genes of Wnt/beta-catenin pathway [38]. The gene discussed is SALL4; the disease is acute myeloid leukemia.